ASX:IMR Imricor Medical Systems (IMR) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free IMR Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume27,486 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Imricor Medical Systems alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About Imricor Medical Systems Stock (ASX:IMR)Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.Read More Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… IMR Stock News HeadlinesApril 15, 2024 | chicago.suntimes.comPritzker pushes plan to erase $1 billion in medical debt for IllinoisansApril 9, 2024 | msn.comMMI secures FDA approval for Symani Surgical SystemApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.April 3, 2024 | msn.com‘Overnight success story 18 years in the making’ – Imricor to transform cardiac ablation marketMarch 20, 2024 | tmcnet.comSystem Integrator Market worth $40.3 billion by 2029 - Exclusive Report by MarketsandMarkets™March 15, 2024 | markets.businessinsider.comBuy Rating Affirmed for REPRO-MED Systems on Strong Growth Prospects and Innovative ExpansionMarch 1, 2024 | finance.yahoo.comImricor Medical Systems Full Year 2023 Earnings: US$0.14 loss per share (vs US$0.12 loss in FY 2022)January 31, 2024 | msn.comMedical-device makers’ stocks jump as procedures keep going strongApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.January 18, 2024 | msn.comASX Health Stocks: Amplia gets FDA green light to commence trial; Recce study meets all primary endpointsJanuary 11, 2024 | markets.businessinsider.comMobile Medical Services DocGo Counters Fuzzy Panda Report, Asserts Fiscal Health And Growth PlansJanuary 10, 2024 | msn.comASX Health Stocks: Lumos, Singular, and Imricor all jump today after deals and approvalsJanuary 5, 2024 | tmcnet.comInspire Medical Systems, Inc. Investors With Large Losses Should Contact Robbins LLP for Information About Their Rights and Remedies Against INSPDecember 29, 2023 | msn.comHow much might that MRI cost in an Idaho hospital? The amount could vary by the thousandsDecember 4, 2023 | marketwatch.comShares of Merit Medical Systems Decline 6.6% on $550M Private Placement OfferingDecember 1, 2023 | markets.businessinsider.comZetrOZ Systems Partners with Military Sports Medicine Providers Delivering Advanced Healing TechnologiesOctober 12, 2023 | msn.comASX Health Stocks: Arovella to develop a world-first iNKT cell therapy targeting cancersSeptember 5, 2023 | msn.comASX Health Stocks: Bod Science surges 20pc on cannabis trial results; Recce gets Vietnam trade markAugust 25, 2023 | finance.yahoo.comImricor Medical Systems First Half 2023 Earnings: US$0.061 loss per share (vs US$0.068 loss in 1H 2022)August 1, 2023 | msn.comASX Small Caps Lunch Wrap: Which weird-looking bear has China up in arms again this morning?July 26, 2023 | forbes.comBest Medical Alert Systems With No Monthly Fee Of 2023June 16, 2023 | forbes.comBest In-Home Medical Alert Systems Of 2023June 9, 2023 | msn.comDartmouth Hitchcock Medical Center laying off dozens of workers later this monthJune 9, 2023 | morningstar.comImricor Medical Systems Inc Chess Depository InterestMay 16, 2023 | businesswire.comIntrance Medical Systems Appoints Ashley Prange as Vice President of Business DevelopmentMay 15, 2023 | benzinga.comIndependent Living Systems Fully Licensed to Provide Home Medical EquipmentMay 2, 2023 | marketwatch.comImplantable Defibrillators Market 2023 Growth Status and Outlook for 2030See More Headlines Receive IMR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Imricor Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:IMR CUSIPN/A CIKN/A Webwww.imricor.com Phone952-818-8400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.21) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-22,630,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-274.56% Return on Assets-95.73% Debt Debt-to-Equity Ratio59.20 Current Ratio0.86 Quick Ratio4.33 Sales & Book Value Annual Sales$867,996.00 Price / Sales0.00 Cash FlowN/A Price / Cash Flow25.56 Book ValueA($0.05) per share Price / BookN/AMiscellaneous Outstanding Shares188,170,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.24 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Steve Wedan (Age 55)President, CEO & Executive Chairman Comp: $721.69kMr. Jonathon GutCFO & VP of FinanceMr. Gregg StenzelChief Operating OfficerMr. Greg EnglehardtSenior Director of SalesMr. Nick TwohyVice President of Marketing & Business DevelopmentMr. Kobe LizhengCompany Secretary & Local AgentMore ExecutivesKey Competitors4DMedicalASX:4DXAdheriumASX:ADRAinosNASDAQ:AIMDWAllegra Medical TechnologiesASX:AMTAnalyticaASX:ALTView All CompetitorsInsidersPeter McGregorSold 78,271 sharesTotal: $35,221.95 ($0.45/share)Steve WedanSold 173,756 sharesTotal: $55,601.92 ($0.32/share)Anita MessalSold 168,539 sharesTotal: $44,662.84 ($0.27/share) IMR Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Imricor Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some companies that other Imricor Medical Systems investors own include Gold Standard Ventures (GSV) and Nuwellis (CHFS). This page (ASX:IMR) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyPrepare for a recession unlike any otherAmerican Hartford Gold GroupWill this $2 AI stock double overnight?Behind the MarketsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imricor Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
